The Panic Evidence Map.
What we know about panic disorder, what we're still figuring out, and what the data can't tell us.
The panic literature is unusually rich. Cognitive behavioral therapy for panic has been studied for forty years, and a few of the questions, like whether exposure adds something to cognitive work, are basically settled. Other questions are still moving. This map shows where the evidence is firm, where it's mixed, and where the studies and the clinic still disagree.
Evidence nodes
What the map shows
Panic disorder isn't rare and it isn't mild. The past-year prevalence sits around 2.7 percent of U.S. adults, and roughly forty percent of those are rated as serious. Around a quarter of patients showing up to emergency rooms with chest pain actually have panic, which says something about where panic shows up in the real world (not always a psychiatrist's office). The treatment evidence is genuinely strong: cognitive behavioral therapy with an exposure component is among the most reliably effective interventions in psychiatry, full stop. SSRIs work too, with smaller average effect sizes than CBT but a different effort profile. The combination tends to outperform either alone for moderately severe cases.
The map ties those threads together so you can see how prevalence, treatment, ED utilization, and long-term outcomes connect.
What the map doesn't show
- ·The prevalence numbers come from NCS-R (2001 to 2003). They're still the canonical U.S. anchor, but they aren't current-year, and no later survey has replicated the full diagnostic interview.
- ·The ED chest-pain panic estimate (around 25 percent) comes from selected clinic samples, not the general population. It tells you what the rate looks like inside chest-pain workups, not what it looks like everywhere.
- ·Treatment effect sizes are averages. Individual response varies, and most studies report dropout rates that complicate the picture. Some of the strongest evidence is on completer samples, which inflates apparent benefit.
- ·Long-term remission depends on how it's defined and how long the follow-up runs. The headline figure you sometimes see in coverage isn't always the figure that holds up after two or three years.
- ·Benzodiazepines have a complicated evidence base. They work in the short term, and the long-term picture (tolerance, discontinuation, cognitive effects) is more honestly summarized as "context-dependent" than as one number.
Sources
How to cite this map
The Panic Evidence Map, AnxietyResearch.org. Built from NIMH National Comorbidity Survey Replication estimates, treatment-outcome meta-analyses for cognitive behavioral therapy and SSRIs in panic disorder, and emergency-department chest-pain cohort studies. Accessed [date]. https://anxietyresearch.org/evidence-maps/panic/
Your next step in The Shrink Network
You are here: AnxietyResearch, the evidence layer of The Shrink Network.
Each site in the network has one job. No matter where you enter, we help you find the next step that makes sense.
Get clinical care at shrinkMDWant to understand more first?